Abstract
The research analyzes a patient-oriented methodology for assessing the results of various options for lymph dissection in gastric cancer based on the study of molecular genetic markers in the non-recombining part of the Y chromosome and in mitochondrial DNA (haplogroups). Significant heterogeneity was established among patients in world randomized trials who underwent resection operations on the stomach with various options for lymph dissection. In the Y chromosome, the haplogroup with the designation O was predominant in patients of Asian studies (59 % - 95 % of cases) with the designation O. The second most frequent (14 % - 72 % of cases, patients in European studies) was the haplogroup R1b. The total number of patients with mitochondrial macrogaplogroup N (mainly haplogroups H and U) was almost twice as many as patients with macrogaplogroup M (D haplogroup). According to the results of our own exploratory study, in all patients operated on for gastric cancer, haplogroup R1a was verified in the Y chromosome. Clusters of macrogaplogroup N (U, H, T) predominated in mitochondrial DNA. Thus, one of the approaches ensuring the homogeneity of comparison groups in assessing various options for lymph dissection in gastric cancer is to assess their comparability based on haploid molecular genetic markers.References
Каприн А.Д., Сулейманов Э.А., Филоненко Е.В. и др. Паллиативная хирургия в сочетании с интраоперационной фотодинамической терапией у больных раком желудка // Паллиативная медицина и реабилитация. - 2017. - № 4. - С. 30-31.
Клинические рекомендации. Рак желудка. http:// oncology-association.ru/docs/rak_zheludka.pdf.
Степанов А.В. Эволюция генетического разнообразия и болезни человека // Генетика. - 2016. - Т. 52(7). - С. 746-756. - 10.7868/ s0016675816070109. DOI: 10.7868/s0016675816070109
Омельяновский В.В. Методические рекомендации по проведению оценки научной обоснованности включаемой в клинические рекомендации информации. - Москва: 2019.
Mocellin S., McCulloch P., Kazi H. et al. Extent of lymph node dissection for adenocarcinoma of the stomach // Cochrane Database of Systematic Reviews. - 2015. - Vol. 8. - CD001964. -10.1002/14651858. CD001964.pub4. DOI: 10.1002/14651858.CD001964.pub4
Robertson C.S., Chung S.C., Woods S.D. et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer // Annals of Surgery. - 1994. - Vol. 220. - P. 176-182.
Cuschieri A., Weeden S., Fielding J. et al. Patient survival after D1 and D2 resections for gastric cancer: long term results of the MRC randomized surgical trial // British Journal of Cancer. - 1999. - Vol. 79. - P 15221530. - DOI: 10.1038/sj.bjc.6690243
Maeta M., Yamashiro H., Saito H. et al. A prospective pilot study of extended (D3) and superextended paraaortic lymphadenectomy (D4) in patients with T3 or T4 gastric cancer managed by total gastrectomy // Surgery. - 1999. - Vol. 125. - P 325-331. - https:// DOI: 10.1067/msy.1999.95974
Wu C.W., Hsiung C.A., Lo S.S. et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial // Lancet Oncology. - 2006. - Vol. 7. - P. 309-315. -. DOI: 10.1016/S1470-2045(06)70623-4
Sasako M., Sano T, Yamamoto S. et al. D2 lymphadenec-tomy alone or with para-aortic nodal dissection for gastric cancer // New England Journal of Medicine. - 2008. - Vol. 359. - P 453-462. - DOI: 10.1056/nej-moa0707035
Yonemura Y, Wu C.C., Fukushima N. et al. Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer // International Journal of Clinical Oncology. - 2008. - Vol. 13. - P. 132137. - DOI: 10.1007/s10147-007-0727-1
Songun I., Putter H., Kranenbarg E.M. et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide DutchD1 D2 trial // Lancet Oncology. - 2010. - Vol. 11. - P 439-449. - https://doi. org/-x. DOI: 10.1016/s1470-2045(10)70070
Degiuli M., Sasako M., Ponti A. et al. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer // British Journal of Surgery. - 2014. - Vol. 101. - P. 23-31. - 10.1002/ bjs.9345. DOI: 10.1002/bjs.9345
Larmuseau M.H., Vanderheyden N., Jacobs M. et al. Micro-geographic distribution of Y-chromosomal variation in the central-western European region Brabant // Forensic Science International: Genetics. - 2011. - Vol. 5(2). - P 95-99. - DOI: 10.1016/j.fsi-gen.2010.08.020
Rootsi S. et al. Phylogeography of Y-chromosome haplogroup I reveals distinct domains of prehistoric gene flow in Europe // Am J Hum Genet. - 2004. - Vol. 75. - P 128-137. -. DOI: 10.1086/422196
Myres N.M., Rootsi S., Lin A.A. et al. A major Y-chromosome haplogroup R1b Holocene era founder effect in Central and Western Europe // Eur J Hum Genet. - 2011. - Vol. 19. - P. 95-101. - DOI: 10.1038/ejhg.2010.146
Underhill PA., Myres N.M., Rootsi S. et al. Separating the post-Glacial coancestry of European and Asian Y chromosomes within haplogroup R1a // Eur J Hum Genet. - 2010. - Vol. 18. - P. 479-484. - https:// DOI: 10.1038/ejhg.2009.194
Brisighelli F. et al. Uniparental markers of contemporary Italian population reveals details on its pre-Roman heritage // PLoS ONE. - 2012. - Vol. 7. - e50794. -10.1371 /annotation/ea14adcb-033d-492d8f8be047aa080cd4. DOI: 10.1371/annotation/ea14adcb-033d-492d8f8be047aa080cd4
Kim S.H., Kim K.C., Shin D.J. et al. High frequencies of Y-chromosome haplogroup O2b-SRY465 lineages in Korea: a genetic perspective on the peopling of Korea // Invest Genet. - 2011. - Vol. 2. - P 10. - https://doi. org/. DOI: 10.1186/2041-2223-2-10
Muro Т., lida R., Fujihara J. et al. Simultaneous determination of seven informative Y chromosome SNPs to differentiate East Asian, European, and African populations // Leg Med (Tokyo). - 2011. - Vol. 13. - P 134-141. - https://doi.org/10.1016Zj.legalmed.2011.01.001.
Балановский О.П. Генофонд Европы. - М.: Товарищество научных изданий КМК, 2015. - 338 с.
Garcia O., Fregel R., Larruga J.M. et al. Using mitochondrial DNA to test the hypothesis of a European postglacial human recolonization from the Franco-Cantabrian refuge. Heredity (Edinb). 2011; 106: 37-45. https://doi. org/. DOI: 10.1038/hdy.2010.47
Chaitanya L., van Oven M., Brauer S. et al. High-quality mtDNA control region sequences from 680 individuals sampled across the Netherlands to establish a national forensic mtDNA reference database // Forensic Sci. Int. Genet. - 2016. - Vol. 21. - P. 158-167. -https://doi. org/. DOI: 10.1016/j.fsigen.2015.12.002
Maruyama S., Minaguchi K., Saitou N. Sequence polymorphisms of the mitochondrial DNA control region and phylogenetic analysis of mtDNA lineages in the Japanese population // Int. J. Legal Med. - 2003. - Vol. 117(4). - P 218-225. - 10.1007/ s00414-003-0379-2. DOI: 10.1007/s00414-003-0379-2
Tanaka M., Cabrera V.M., Gonzalez A.M. et al. Mitochondrial genome variation in eastern Asia and the peopling of Japan // Genom. Res. - 2004. - Vol. 14. - P 18321850. -. DOI: 10.1101/gr.2286304
Yamamoto M., Rashid O.M., Wong J. Surgical management of gastric cancer: the East vs. West perspective // J. Gastrointest Oncol. - 2015. - Vol. 6. - P. 79-88. -. DOI: 10.3978/j.issn.2078-6891.2014.097
Степанов В.А., Харьков В.Н., Пузырев В.П. Эволюция и филогеография линий Y- хромосомы человека // Вестник ВоГиС. - 2006. - Т. 10(1). - С. 57-73.
Wang H., Wang Y, Zhao Q. et al. Identification of sequence polymorphisms in the D-Loop region of Mitochondrial DNA as a risk factor for gastric cancer // Mitochondrial DNA. - 2016. - Vol. 27(2). - P. 1045-1047. - https:// DOI: 10.3109/19401736.2014.926546
Wang C., Wang Y, Wang H. et al. Mitochondrial DNAhaplogroup N is associated good outcome of gastric cancer // Tumour Biol. - 2014. - Vol. 35. - P. 1255512559. - https://doi.org/10.100J/s13277-014-2575-8.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2020